Company intelligence / Profile preview

Serabi

San Francisco, California, United States

Ownership: Private
Development stage: Other

Overview

Sarabi Bio is an early-stage biotechnology company focused on the development of next-generation genetic medicines. Founded by industry veterans with significant experience in gene therapy, the company aims to address unmet medical needs in genetic and neuromuscular disorders. Sarabi Bio leverages advanced delivery technologies and therapeutic constructs to improve the efficacy and safety of genetic treatments. The company operates primarily in a stealth or early-development mode, focusing on building a robust pipeline of transformative therapies.

Therapeutic areas: Rare DiseasesNeurology
Modalities: Gene therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on Serabi.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serabi.

Explore the full profile